2,1,3-Benzothiadiazoles as myolonolytics
Patent 4053617 Issued on October 11, 1977. Estimated Expiration Date: 
October 11, 1994. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
October 11, 1994. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References3843668 InventorsAssigneeApplicationNo. 05/708621 filed on 07/26/1976US Classes:514/362, 1,2,5-thiadiazoles (including hydrogenated)514/906MUSCLE RELAXANTExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassA61K 31/425 (20060101)Foreign Application Priority Data1975-07-28 UKAbstractThis invention provides a new myotonolytic use of 2,1,3-benzothiadiazole derivatives and novel pharmaceutical compositions for such use. | |
